{"id":"https://openalex.org/W1998997365","doi":"https://doi.org/10.1093/jnci/92.5.418","title":"A Ligand of Peroxisome Proliferator-Activated Receptor gamma, Retinoids, and Prevention of Preneoplastic Mammary Lesions","display_name":"A Ligand of Peroxisome Proliferator-Activated Receptor gamma, Retinoids, and Prevention of Preneoplastic Mammary Lesions","alternate_titles":[],"publication_year":2000,"publication_date":"2000-03-01","ids":{"openalex":"https://openalex.org/W1998997365","doi":"https://doi.org/10.1093/jnci/92.5.418","mag":"1998997365","pmid":"https://pubmed.ncbi.nlm.nih.gov/10699072"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/92.5.418","doi":"https://doi.org/10.1093/jnci/92.5.418","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/92.5.418","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998997365"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5012645747","display_name":"Rajendra G. Mehta","orcid":"https://orcid.org/0000-0003-4960-6188","observed_orcids":["https://orcid.org/0000-0003-4960-6188"]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]},{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]},{"id":"https://openalex.org/I39422238","display_name":"University of Illinois Chicago","ror":"https://ror.org/02mpq6x41","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"R. G. Mehta","raw_affiliation_strings":["Department of Surgical Oncology, College of Medicine, University of Illinois, Chicago, IL 60612, USA","Affiliations of authors: R. G. Mehta, M. K. Patel, Department of Surgical Oncology,\r\nCollege of Medicine, University of\r\nIllinois, Chicago","E. Williamson, H. P. Koeffler, Hematology/Oncology\r\nDivision, Cedars-Sinai Medical Center/University of California at Los\r\nAngeles School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgical Oncology, College of Medicine, University of Illinois, Chicago, IL 60612, USA","institution_ids":["https://openalex.org/I39422238"]},{"raw_affiliation_string":"Affiliations of authors: R. G. Mehta, M. K. Patel, Department of Surgical Oncology,\r\nCollege of Medicine, University of\r\nIllinois, Chicago","institution_ids":["https://openalex.org/I39422238"]},{"raw_affiliation_string":"E. Williamson, H. P. Koeffler, Hematology/Oncology\r\nDivision, Cedars-Sinai Medical Center/University of California at Los\r\nAngeles School of Medicine","institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161610107","display_name":"E Williamson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E Williamson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161522159","display_name":"M K Patel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M K Patel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5161530125","display_name":"H P Koeffler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H P Koeffler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5012645747"],"corresponding_institution_ids":["https://openalex.org/I1282927834","https://openalex.org/I161318765","https://openalex.org/I39422238"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":2.9129,"has_fulltext":false,"cited_by_count":149,"citation_normalized_percentile":{"value":0.917217,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"92","issue":"5","first_page":"418","last_page":"423"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9775000214576721,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer-chemoprevention","display_name":"breast cancer chemoprevention","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.7179999947547913},{"id":"https://openalex.org/keywords/troglitazone","display_name":"troglitazone","score":0.9079999923706055},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9070000052452087},{"id":"https://openalex.org/keywords/retinoids","display_name":"retinoids","score":0.9319999814033508},{"id":"https://openalex.org/keywords/all-trans-retinoic-acid","display_name":"all-trans retinoic acid","score":0.9739999771118164},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-alpha","display_name":"retinoic acid receptor alpha","score":0.8500000238418579},{"id":"https://openalex.org/keywords/retinoid-x-receptor","display_name":"retinoid X receptor","score":0.9070000052452087},{"id":"https://openalex.org/keywords/7-12-dimethylbenz-a-anthracene","display_name":"7,12-dimethylbenz(a)anthracene","score":0.9449999928474426},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5049999952316284}],"concepts":[{"id":"https://openalex.org/C2778150266","wikidata":"https://www.wikidata.org/wiki/Q7844989","display_name":"Troglitazone","level":4,"score":0.9597021341323853},{"id":"https://openalex.org/C2778938436","wikidata":"https://www.wikidata.org/wiki/Q5205596","display_name":"DMBA","level":4,"score":0.6829356551170349},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.6655886769294739},{"id":"https://openalex.org/C68484354","wikidata":"https://www.wikidata.org/wiki/Q17516011","display_name":"Retinoid X receptor alpha","level":5,"score":0.6348270177841187},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5697883367538452},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5593074560165405},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.5486326217651367},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.5387632846832275},{"id":"https://openalex.org/C128821507","wikidata":"https://www.wikidata.org/wiki/Q3454518","display_name":"Retinoid X receptor","level":5,"score":0.5154908299446106},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.48755139112472534},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36751610040664673},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3665846586227417},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36597877740859985},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3637177348136902},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33675992488861084},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.32145044207572937},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.218529611825943},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.18683460354804993},{"id":"https://openalex.org/C555283112","wikidata":"https://www.wikidata.org/wiki/Q1637543","display_name":"Carcinogenesis","level":3,"score":0.08865711092948914},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.052781254053115845},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000072482","descriptor_name":"Retinoic Acid Receptor alpha","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077288","descriptor_name":"Troglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000097768","descriptor_name":"Retinoic Acid Receptor gamma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002273","descriptor_name":"Carcinogens","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002839","descriptor_name":"Chromans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004958","descriptor_name":"Estradiol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008024","descriptor_name":"Ligands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008321","descriptor_name":"Mammary Glands, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D008321","descriptor_name":"Mammary Glands, Animal","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D008325","descriptor_name":"Mammary Neoplasms, Experimental","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009924","descriptor_name":"Organ Culture Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011230","descriptor_name":"Precancerous Conditions","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011230","descriptor_name":"Precancerous Conditions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D011374","descriptor_name":"Progesterone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014157","descriptor_name":"Transcription Factors","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D014212","descriptor_name":"Tretinoin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015127","descriptor_name":"9,10-Dimethyl-1,2-benzanthracene","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018160","descriptor_name":"Receptors, Cytoplasmic and Nuclear","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018168","descriptor_name":"Receptors, Retinoic Acid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047488","descriptor_name":"Retinoid X Receptors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/92.5.418","doi":"https://doi.org/10.1093/jnci/92.5.418","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/92.5.418","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:10699072","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10699072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.554.5263","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.554.5263","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/92/5/418.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2460854453","display_name":null,"funder_award_id":"CA 26038-20","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8251651957","display_name":"Pax5:Hematopoietic Transcription Factor Involved in ALL","funder_award_id":"R01CA026038","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":46,"referenced_works":["https://openalex.org/W238738382","https://openalex.org/W566534948","https://openalex.org/W1224318197","https://openalex.org/W1586597239","https://openalex.org/W1617897652","https://openalex.org/W1633340712","https://openalex.org/W1639924204","https://openalex.org/W1845857658","https://openalex.org/W1871698357","https://openalex.org/W1965769603","https://openalex.org/W1968094237","https://openalex.org/W1975160900","https://openalex.org/W1975421048","https://openalex.org/W1976621212","https://openalex.org/W1978432350","https://openalex.org/W1984509210","https://openalex.org/W1985784075","https://openalex.org/W1993342645","https://openalex.org/W1995790201","https://openalex.org/W1996499493","https://openalex.org/W2002950936","https://openalex.org/W2003421697","https://openalex.org/W2005674716","https://openalex.org/W2018598399","https://openalex.org/W2019195740","https://openalex.org/W2031694725","https://openalex.org/W2041270901","https://openalex.org/W2042618169","https://openalex.org/W2050717908","https://openalex.org/W2066091675","https://openalex.org/W2086309252","https://openalex.org/W2088404163","https://openalex.org/W2091321756","https://openalex.org/W2099786464","https://openalex.org/W2100136835","https://openalex.org/W2103633745","https://openalex.org/W2106643036","https://openalex.org/W2139002144","https://openalex.org/W2139993271","https://openalex.org/W2141647078","https://openalex.org/W2145619359","https://openalex.org/W2167599338","https://openalex.org/W2170831952","https://openalex.org/W2172256092","https://openalex.org/W2327237185","https://openalex.org/W2461782658"],"related_works":["https://openalex.org/W2042027675","https://openalex.org/W2317346851","https://openalex.org/W2319802160","https://openalex.org/W2101676749","https://openalex.org/W7309100","https://openalex.org/W2080991351","https://openalex.org/W2228311059","https://openalex.org/W2334906759","https://openalex.org/W1505221121"],"abstract_inverted_index":{"BACKGROUND:":[0],"Chemoprevention":[1],"of":[2,9,32,50,62,79,96,124,129,179,194,214,220,248,253,266,276,293],"breast":[3,33],"cancer":[4,34],"is":[5,286],"an":[6,301],"active":[7],"area":[8],"investigation.":[10],"Recent":[11],"in":[12,15,54,68,92,119],"vivo":[13],"and":[14,24,109,133,135,156,225,238,255,279],"vitro":[16],"studies":[17],"have":[18],"shown":[19],"that":[20],"thiazolidinediones":[21],"(e.g.,":[22],"troglitazone)":[23],"retinoids":[25],"are":[26,162],"able":[27],"to":[28,58,88,211,306],"inhibit":[29,212],"the":[30,48,60,122,152,177,192,195,246,260,264,274,287,291],"growth":[31],"cells.":[35],"Troglitazone":[36,165],"mediates":[37],"its":[38],"action":[39],"via":[40],"peroxisome":[41],"proliferator-activated":[42],"receptor":[43,106],"gamma":[44],"(PPARgamma).":[45],"We":[46],"evaluated":[47],"ability":[49,210],"troglitazone,":[51,97],"alone":[52,206],"or":[53,118,169,203,230],"combination":[55,219,275],"with":[56,84,259,273],"retinoids,":[57],"prevent":[59],"induction":[61],"preneoplastic":[63,90],"lesions":[64,91,125,181],"by":[65,139,147],"7,12-dimethylbenz[a]anthracene":[66],"(DMBA)":[67],"a":[69,218,294],"mouse":[70],"mammary":[71,180,249],"gland":[72],"organ":[73,93],"culture":[74],"model.":[75],"METHODS:":[76],"Mammary":[77],"glands":[78],"BALB/c":[80],"mice":[81],"were":[82,126],"treated":[83],"DMBA":[85],"(2":[86],"microg/mL)":[87],"induce":[89],"culture.":[94],"Effects":[95],"all-trans-retinoic":[98],"acid":[99,105,171,278],"(retinoic":[100],"acid;":[101],"ligand":[102,296],"for":[103,112],"retinoic":[104,170,277],"[RAR]":[107],"alpha),":[108],"LG10068":[110,199,221],"(ligand":[111],"retinoid":[113,130],"X":[114],"receptors":[115,131],"[RXRs]),":[116],"singly":[117],"combination,":[120],"on":[121],"development":[123,178,213,247],"evaluated.":[127],"Expression":[128],"(RARalpha":[132],"RXRalpha)":[134],"PPARgamma":[136,254,295],"was":[137,145,268],"determined":[138,146],"western":[140],"blot":[141],"analysis.":[142],"Statistical":[143],"significance":[144],"generalized":[148],"chi-squared":[149],"analysis":[150],"using":[151],"GENCAT":[153],"software":[154],"program":[155],"Bonferroni":[157],"correction.":[158],"All":[159],"P":[160,183,242],"values":[161,184,243],"two-sided.":[163],"RESULTS:":[164],"(at":[166,172,200,222,227],"10(-5)":[167,228],"M)":[168,174,205,224,232],"10(-6)":[173,231],"markedly":[175],"inhibited":[176,235],"(both":[182],"<.05);":[185],"however,":[186],"together":[187],"they":[188],"did":[189],"not":[190],"enhance":[191,307],"effectiveness":[193],"other.":[196],"In":[197],"contrast,":[198],"10(-7)":[201],"M":[202,229],"10(-8)":[204,223],"had":[207],"very":[208],"little":[209],"these":[215],"lesions,":[216],"but":[217],"troglitazone":[226],"almost":[233],"completely":[234],"(by":[236],"85%":[237],"100%,":[239],"respectively;":[240],"both":[241],"<.":[244],"05)":[245],"lesions.":[250],"The":[251],"expression":[252,265],"RXRalpha":[256],"remained":[257],"unchanged":[258],"various":[261],"treatments,":[262],"whereas":[263],"RARalpha":[267],"substantially":[269],"reduced":[270],"after":[271],"treatment":[272],"troglitazone.":[280],"CONCLUSIONS:":[281],"To":[282],"our":[283],"knowledge,":[284],"this":[285,308],"first":[288],"report":[289],"showing":[290],"possibility":[292],"having":[297],"chemopreventive":[298],"activity.":[299,309],"Furthermore,":[300],"RXR-selective":[302],"retinoid,":[303],"LG10068,":[304],"appears":[305]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998997365","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
